BRPI1005306A2 - método para a análise de câncer de mama e produto de programa de computador - Google Patents

método para a análise de câncer de mama e produto de programa de computador

Info

Publication number
BRPI1005306A2
BRPI1005306A2 BRPI1005306A BRPI1005306A BRPI1005306A2 BR PI1005306 A2 BRPI1005306 A2 BR PI1005306A2 BR PI1005306 A BRPI1005306 A BR PI1005306A BR PI1005306 A BRPI1005306 A BR PI1005306A BR PI1005306 A2 BRPI1005306 A2 BR PI1005306A2
Authority
BR
Brazil
Prior art keywords
program product
breast cancer
computer program
presented
cancer analysis
Prior art date
Application number
BRPI1005306A
Other languages
English (en)
Inventor
Janevski Angel
B Hicks James
Kamalakaran Sitharthan
Original Assignee
Cold Spring Harbor Laboratory
Koninl Philips Electronics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cold Spring Harbor Laboratory, Koninl Philips Electronics Nv filed Critical Cold Spring Harbor Laboratory
Publication of BRPI1005306A2 publication Critical patent/BRPI1005306A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/165Mathematical modelling, e.g. logarithm, ratio
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

métodos para a subclassificação de tumores de mama é apresentado um método para a análise de câncer de mama, o qual compreende a determinação do estado de metilação genômico de um ou mais dinucleotídeos cpg. além disso, é apresentado um produto de programa de computador armazenado em uma mídia que pode ser lida por computador que compreende um código de programa adaptado para executar as etapas do método quando executado em um aparelho para processamento de dados. um dispositivo que compreende meios para auxiliar um médico também é apresentado.
BRPI1005306A 2009-01-30 2010-01-25 método para a análise de câncer de mama e produto de programa de computador BRPI1005306A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14841309P 2009-01-30 2009-01-30
PCT/IB2010/050316 WO2010086782A2 (en) 2009-01-30 2010-01-25 Methods for the subclassification of breast tumours

Publications (1)

Publication Number Publication Date
BRPI1005306A2 true BRPI1005306A2 (pt) 2019-03-19

Family

ID=42224291

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1005306A BRPI1005306A2 (pt) 2009-01-30 2010-01-25 método para a análise de câncer de mama e produto de programa de computador

Country Status (8)

Country Link
US (1) US20120004118A1 (pt)
EP (2) EP2391735A2 (pt)
JP (1) JP2012517215A (pt)
KR (1) KR20110113642A (pt)
CN (1) CN102549165A (pt)
BR (1) BRPI1005306A2 (pt)
RU (1) RU2011135955A (pt)
WO (1) WO2010086782A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012102377A1 (ja) * 2011-01-28 2012-08-02 独立行政法人国立がん研究センター 肝細胞癌のリスク評価方法
CN110229913B (zh) * 2019-07-19 2022-10-11 上海奕谱生物科技有限公司 基于甲基化水平检测肿瘤的广谱性标记物及其应用
CN116121371A (zh) * 2022-07-06 2023-05-16 武汉艾米森生命科技有限公司 检测tlx1基因中目标区域的甲基化水平的试剂在制备食管癌诊断产品中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8076063B2 (en) * 2000-02-07 2011-12-13 Illumina, Inc. Multiplexed methylation detection methods
US20050021240A1 (en) 2000-11-02 2005-01-27 Epigenomics Ag Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the DNA
ATE429511T1 (de) * 2001-03-01 2009-05-15 Epigenomics Ag Verfahren zur entwicklung von gensätzen zu diagnostischen und therapeutischen zwecken auf grundlage des expressions- und methylierungsstatus der gene
JP2004033210A (ja) * 2002-02-20 2004-02-05 Ncc Technology Ventures Pte Ltd 癌診断に関する物および方法
US7991557B2 (en) * 2004-06-19 2011-08-02 Genenews Corporation Computer system and methods for constructing biological classifiers and uses thereof
WO2005123945A2 (en) * 2004-06-21 2005-12-29 Epigenomics Ag Epigenetic markers for the treatment of breast cancer
EP2281902A1 (en) * 2004-07-18 2011-02-09 Epigenomics AG Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders
CA2612021A1 (en) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
WO2007019670A1 (en) * 2005-07-01 2007-02-22 Graham, Robert Method and nucleic acids for the improved treatment of breast cancers
JPWO2007026960A1 (ja) * 2005-08-31 2009-03-12 リンク・ジェノミクス株式会社 Mocs3遺伝子の治療的又は診断的用途
EP2024515B1 (en) * 2006-05-31 2012-08-22 Orion Genomics, LLC Gene methylation in cancer diagnosis
EP2052355A2 (en) * 2006-08-11 2009-04-29 Koninklijke Philips Electronics N.V. Methods and apparatus to integrate systematic data scaling into genetic algorithm-based feature subset selection
EP2097538A4 (en) * 2006-12-07 2011-11-30 Switchgear Genomics TRANSCRIPTION REAGULATION ELEMENTS OF BIOLOGICAL PATHS, TOOLS AND METHODS
US20090203011A1 (en) * 2007-01-19 2009-08-13 Epigenomics Ag Methods and nucleic acids for analyses of cell proliferative disorders
CN101861398A (zh) * 2007-09-17 2010-10-13 皇家飞利浦电子股份有限公司 用于乳腺癌紊乱分析的方法
EP2279478A1 (en) * 2008-05-12 2011-02-02 Koninklijke Philips Electronics N.V. A medical analysis system
WO2010070572A1 (en) * 2008-12-18 2010-06-24 Koninklijke Philips Electronics N. V. Method for the detection of dna methylation patterns
US20120004855A1 (en) * 2008-12-23 2012-01-05 Koninklijke Philips Electronics N.V. Methylation biomarkers for predicting relapse free survival
WO2011036604A2 (en) * 2009-09-22 2011-03-31 Koninklijke Philips Electronics N.V. Method and compositions for assisting in diagnosing and/or monitoring breast cancer progression

Also Published As

Publication number Publication date
WO2010086782A8 (en) 2011-12-08
EP2955235A3 (en) 2016-03-02
EP2391735A2 (en) 2011-12-07
RU2011135955A (ru) 2013-03-10
WO2010086782A2 (en) 2010-08-05
KR20110113642A (ko) 2011-10-17
WO2010086782A3 (en) 2010-11-25
EP2955235A2 (en) 2015-12-16
JP2012517215A (ja) 2012-08-02
CN102549165A (zh) 2012-07-04
US20120004118A1 (en) 2012-01-05

Similar Documents

Publication Publication Date Title
MX2013000457A (es) Metodo para evaluar el riesgo de nacimientos multiples en tratamientos de infertilidad.
BR112013030366A2 (pt) método, aparelho e produto de programa de computador
BR112015027830A2 (pt) método e sistema de identificação de biomarcador
MX342735B (es) Diagnostico acompañante para terapia con agente anti-hialuronano y metodos de uso del mismo.
MX2021015008A (es) Sistemas y metodos de deteccion de cancer.
BR112014032312A2 (pt) aparelho e método de exibição de informação de dispositivo de usuário
EP2291722A4 (en) METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR OBTAINING GESTURE ANALYSIS
WO2016109782A3 (en) Methods and compositions for detecting colorectal neoplasias
BR112014031978A2 (pt) sistema e método de registro de uma sequência de imagens, estação de trabalho ou aparelho de formação de imagens, e, produto de programa de computador
BR112012006402A2 (pt) método e aparelho configurado para estimar a localização de um dispositivo de usuário em uma rede sem fio, e, programa de computador.
BRPI1005306A2 (pt) método para a análise de câncer de mama e produto de programa de computador
BR112013025601A2 (pt) sistema de processamento de imagens, dispositivo manual, estação de trabalho, método para permitir ao usuário navegar através de dados de imagens e produto de programa de computador
BR112016028427A2 (pt) método para monitoramento de uma bomba submersível elétrica, sistema de monitoramento de uma bomba submersível elétrica, e meio legível por computador não transitório
BR112017012259A2 (pt) método para processamento de dados relacionados à formação terrestre, dispositivo de armazenamento legível por máquina não transitório, e, sistema.
BR112015001983A2 (pt) processamento de solicitações
BR112015022214A2 (pt) aparelho e métodos para gerenciar informações de produto de resíduo
BR112013029069A2 (pt) sistema para realizar uma pesquisa de um documento em uma coleção de documentos, estação de trabalho, método de realização de uma pesquisa de um documento e produto de programa de computador
Mies et al. Epigenetic biomarkers are applicable for risk stratification in myelodysplastic syndromes
Ambarwati et al. Parity Early Stage of Marriage with Incidence of Postpartum Depression
Gluz et al. 11O Prospective Comparison of Risk Assessment Tools in Early Breast Cancer: Correlation Analysis from the Phase III Wsg-Plan B Trial
庞亚飞 The Transitivity Analysis of A Woman on a Roof
WANG et al. Domestic publications of papers on public health and preventive medicine written by professionals in some universities in China, 2008-2012: a biblimetric study
Ay Risk stratification and prevention of venous thromboembolic disease in cancerology
Durigova et al. Genomic Profile of Early Stage Node-Negative Luminal Breast Cancer Associated with Short Disease-Specific Survival
Pimentel et al. Tumour-Immune System Interactions in Breast Cancer: the Role of Pd-L1, Pd-L2 and Cd86 Expression

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2516 DE 26-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]